Search

everythinglearnresearchcommunity

for

Search:↓

The research identified 12 antioxidant compounds in Polygonum multiflorum roots, suggesting these as quality markers for the plant's processed roots.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Phototherapy is effective in treating vitiligo.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

OG6, a sugar-based material, can stimulate hair growth.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Some breast cancer chemotherapy can cause permanent hair loss.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

PCOS is linked to low-grade chronic inflammation.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.